Schmuth Matthias, Gruber Robert, Elias Peter M, Williams Mary L
Department of Dermatology, University of California, VAMC Metabolism 111F, 4150 Clement Street, San Francisco, CA 94121, USA.
Adv Dermatol. 2007;23:231-56. doi: 10.1016/j.yadr.2007.07.011.
The genetic causes of most of the disorders of cornification have been uncovered. We now face the significant task of delineating how these mutations result in specific phenotypes. Because the permeability barrier resides in the extracellular lipid-enriched domains of the stratum corneum, it was anticipated that disorders of lipid metabolism would perturb the lamellar membrane structures of the extracellular domains and would result in a defective barrier. Unanticipated was the finding that inherited disorders of corneocyte proteins also exhibit, to varying degrees, an impaired permeability barrier. The effect of these corneocyte mutations on barrier function have shed light on how corneocytes interact with the intercellular lamellae to provide the barrier. In some entities, an impaired scaffold leads to fragmented and foreshortened lamellar membranes (e.g., transglutaminase-deficient lamellar ichthyosis, loricrin keratoderma). In others, there is impaired lamellar body secretion (e.g., epidermolytic hyperkeratosis) and altered lipid processing (e.g., Netherton syndrome), leading to deficiency of lamellar membrane structures. The combined insights from delineation of the pathogenesis of lipid metabolic defects and corneocyte protein abnormalities can be used to develop a function-driven model of disease pathogenesis. This model will aid in the development of more targeted approaches to therapy and in understanding some systemic complications of these disorders.
大多数角化障碍的遗传病因已被查明。我们现在面临着一项重大任务,即阐明这些突变如何导致特定的表型。由于渗透屏障存在于角质层富含细胞外脂质的区域,因此预计脂质代谢紊乱会扰乱细胞外区域的板层膜结构,并导致屏障功能缺陷。出乎意料的是,发现角质形成细胞蛋白的遗传性疾病也不同程度地表现出渗透屏障受损。这些角质形成细胞突变对屏障功能的影响揭示了角质形成细胞如何与细胞间板层相互作用以提供屏障。在某些情况下,支架受损会导致板层膜破碎和缩短(例如,转谷氨酰胺酶缺乏性板层状鱼鳞病、loricrin角化病)。在其他情况下,板层小体分泌受损(例如,表皮松解性角化过度)和脂质加工改变(例如,Netherton综合征),导致板层膜结构缺乏。对脂质代谢缺陷和角质形成细胞蛋白异常发病机制的综合见解可用于建立疾病发病机制的功能驱动模型。该模型将有助于开发更具针对性的治疗方法,并有助于理解这些疾病的一些全身并发症。